AI Summary

A prescription‑only, at‑home wearable for treating depression has launched in the United States. The device, marketed by Swedish company Flow Neuroscience, is positioned as an alternative to the antidepressant medications that roughly one‑in‑six American adults currently use. The headset features a futuristic design and carries a four‑figure price tag, which could limit early adoption among patients. It is now available for purchase through a medical prescription.

AI summaries can be wrong sometimes—always verify important details using the source article.